
Chinese biotechnology company headquartered in the Wuhan Optics Valley biological city in Hubei, building an industrial-scale exosome manufacturing platform and developing next-generation exosome-based innovative medicines and regenerative medicine products, with a joint research centre with Northwest University in Xi'an, Shaanxi. Founded by scientists among the earliest in China to work on exosome research together with drug development, process development and commercial specialists, it has published more than twenty research papers and holds over ten invention patents and software copyrights, and is recognised as a national high-tech enterprise, a national technology-based small and medium enterprise, a Hubei innovative SME and a Wuhan 3551 Optics Valley talent programme company.
Unternehmensprofil ansehen
Bewertung hinterlassen